PT-141 · format comparison · research use only
PT-141 nasal spray vs injection: which format fits the protocol.
PT-141 (bremelanotide) is a melanocortin-receptor agonist studied in sexual-behaviour and CNS-signalling research. It appears in the literature in two delivery formats — intranasal and injectable. This page compares the two as research formats and covers what Titan actually stocks: a pre-formatted 15mL intranasal spray, documented per lot.
The intranasal format
The 15mL PT-141 nasal spray is pre-formatted at 1mg per actuation — no lyophilized vial to reconstitute, no draw-up step. For protocols designed around intranasal delivery, the format removes reconstitution variability and the handling steps that come with a powder. It is the format Titan stocks.
View the nasal spray →The injectable format
Injectable PT-141 is supplied as a lyophilized powder reconstituted with bacteriostatic water before subcutaneous research use. It carries more total peptide per unit and lets a protocol control concentration precisely, at the cost of the reconstitution and draw-up steps. Titan's current PT-141 SKU is the intranasal spray; the injectable is the comparison reference here.
PT-141 sourcing →How to choose between them
The compound is identical; the choice is the delivery format your study design calls for. Intranasal removes reconstitution and is convenient for repeated-dosing protocols; injectable gives precise concentration control and higher total payload per unit. Neither is a quality difference — both should carry the same per-lot documentation standard.
Nasal peptide category →Documentation either way
Whichever format, the quality screen is the paperwork: a lot-matched release sheet keyed to the code on the unit, with an HPLC main-peak purity result and a mass-spec identity confirmation — not a generic spec sheet reused across batches. Titan's nasal spray ships with this lot-matched documentation on request.
How to read the COA →How checkout settles
Titan is crypto-only — BTC, USDC, or SOL. The network and wallet are shown before payment and an order ID is logged with support first. Paying in USDC holds the total at the quoted figure. The 15mL PT-141 nasal spray is listed at $69.99 with FIRST10/BULK15/TITAN20/VIP25 codes at checkout.
Crypto checkout walkthrough →Storage by format
A lyophilized injectable vial and an intranasal solution store differently. Titan documents the nasal-format storage and shelf-life expectations so the material in the bottle behaves predictably across a study window rather than degrading silently.
Nasal spray storage guide →The detail, in plain terms
Two formats, one compound, one documentation standard.
PT-141 (bremelanotide) appears in the research literature both intranasally and by injection. The format is a delivery choice, not a quality one — but the per-lot documentation should be identical in either case.
- Compound
- PT-141 (bremelanotide) — melanocortin-receptor agonist peptide.
- Nasal format
- 15mL intranasal spray · 1mg per actuation, $69.99 — what Titan stocks.
- Injectable format
- Lyophilized powder, reconstituted for SC research — comparison reference.
- Choose nasal for
- Convenience, no reconstitution, repeated-dosing protocols.
- Choose injectable for
- Precise concentration control, higher total payload per unit.
- Checkout
- Crypto-only — BTC, USDC, SOL; on-chain confirm before dispatch.
Questions researchers ask
Before you order.
- What is the difference between PT-141 nasal spray and injection?
- The compound (bremelanotide) is identical — the difference is delivery format. The intranasal spray is pre-formatted at a set concentration per actuation with no reconstitution; the injectable is a lyophilized powder reconstituted with bacteriostatic water for subcutaneous research, giving precise concentration control. The choice is the format your protocol calls for, not a quality difference.
- Which PT-141 format does Titan sell?
- Titan stocks the intranasal format: a 15mL PT-141 nasal spray at 1mg per actuation, listed at $69.99, supplied with a lot-matched release sheet and an HPLC purity target. It is sold strictly for in-vitro laboratory research, not for human use.
- Is the nasal spray or injection better for research?
- Neither is inherently better — it depends on the study design. Intranasal removes reconstitution variability and is convenient for repeated-dosing protocols; injectable gives precise concentration control and a higher total payload per unit. Both should carry the same per-lot documentation standard.
- Does the PT-141 nasal spray come with a COA?
- Yes — a lot-matched release sheet is available, tied to the lot code on the spray bottle, with an HPLC main-peak purity result and a mass-spec identity confirmation, rather than a stock spec sheet reused across batches.
- Is PT-141 approved for human use?
- Research-grade PT-141 sold as a reagent is not for human use. Titan supplies it strictly as a research-use-only compound for in-vitro laboratory work — not for human or animal consumption, and not for diagnostic, therapeutic, or preventative use.